Nonpeptidic Irreversible Inhibitors of SARS-CoV-2 Main Protease with Potent Antiviral Activity-Reference-Cited by-同舟云学术

Nonpeptidic Irreversible Inhibitors of SARS-CoV-2 Main Protease with Potent Antiviral Activity

Published:2024-08-15 Issue:17 Volume:67 Page:14986-15011
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Oneto Angelo¹²^ORCID,Hamwi Ghazl Al¹²,Schäkel Laura¹²,Krüger Nadine³,Sylvester Katharina¹²,Petry Marvin¹²,Shamleh Rasha Abu¹²,Pillaiyar Thanigaimalai¹²^ORCID,Claff Tobias¹²^ORCID,Schiedel Anke C.¹²,Sträter Norbert⁴^ORCID,Gütschow Michael¹²^ORCID,Müller Christa E.¹²^ORCID

Affiliation:

1. Pharmaceutical Institute, Pharmaceutical & Medicinal Chemistry, University of Bonn, An der Immenburg 4, Bonn D-53121, Germany

2. PharmaCenter Bonn, University of Bonn, Brühler Straße 7, Bonn D-53121, Germany

3. Platform Infection Models, German Primate Center, Leibniz Institute for Primate Research Göttingen, Kellnerweg 4, Göttingen 37077, Germany

4. Center for Biotechnology and Biomedicine, Leipzig University, Deutscher Platz 5, Leipzig 04103, Germany

Funder

Volkswagen Foundation

Publisher

American Chemical Society (ACS)

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.4c00535

Reference64 articles.

1. Omicron variant of SARS‐CoV‐2: Genomics, transmissibility, and responses to current COVID‐19 vaccines

2. Considerable escape of SARS-CoV-2 Omicron to antibody neutralization

3. The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2

4. Severe Acute Respiratory Syndrome (SARS): Development of Diagnostics and Antivirals

5. World Health Organization. Middle East respiratory syndrome coronavirus (MERS-CoV). https://www.who.int/health-topics/middle-east-respiratory-syndrome-coronavirus-mers/ (accessed Feb 2, 2024).